March 27, 2026
Lawdragon has selected twenty-four Cohen Milstein attorneys to the 9th edition of the 2026 500 Leading Plaintiff Financial Lawyers.
We are particularly pleased that Sharon Robertson, a partner in our Antitrust practice, was profiled by Lawdragon for its headline feature. Sharon is a standout in pharmaceutical antitrust litigation, leading the firm’s innovative pay-for-delay lawsuits alleging pharmaceutical brand manufacturers entered non-compete agreements with generic manufacturers to delay entry of lower-priced generic products. She also leads claims that some generic drug manufacturers conspired to inflate prices of their drug products.
- Gary Azorsky – Whistleblower
- Molly Bowen – Securities Litigation
- Robert Braun – Antitrust Litigation
- Benjamin Brown – Antitrust & Competition Law
- S. Douglas Bunch – Securities Litigation
- Manuel Dominguez – Antitrust & Competition Law
- Suzanne Dugan – Securities Litigation; Ethics & Fiduciary Counseling
- Michael Eisenkraft – Securities Litigation & Antitrust
- Andrew Friedman – Commercial Litigation, esp. Securities, Data Breach
- Carol Gilden – Securities Litigation
- Geoffrey Graber – Class Action, Consumer, Privacy
- Brent Johnson – Antitrust
- Eric Kafka – Class Action, Consumer, Privacy
- Richard Koffman – Antitrust & Competition Law
- Emmy Levens – Antitrust & Toxic Torts
- Jeanne Markey – Whistleblower
- Daniel McCuaig – Antitrust
- Kit Pierson – Antitrust & Competition Law
- Laura Posner – Securities Litigation
- Julie Reiser – Securities Litigation
- Sharon Robertson – Antitrust & Competition Litigation
- Christina Saler – Securities Litigation
- Daniel Sommers – Securities Litigation
- Steven Toll – Commercial Litigation, esp. Securities & Class Actions | Lawdragon Hall of Fame
The annual guide features “amazing advocates [who] find pathways to justice for investors who have been defrauded, companies who have been blocked from fair competition and consumers who have been duped, hornswoggled and otherwise had their rights trampled on by ruthless corporations, from social media to pharmaceuticals”.
View the complete 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers list.